OnePin learning desk

Peptide glossary

82 terms for reading research and protocol pages with less guesswork. Every definition includes a worked example; none introduces a dosing value.

Browse A–Z ↓ Practical FAQ →

A

↑

Agonist: A molecule that binds to a receptor and activates it, producing a biological response.

Worked example
A pathway diagram labels the compound as an agonist when it turns receptor signaling on rather than merely occupying the receptor.
Albumin binding: Reversible attachment to albumin in blood, often used to slow clearance and extend exposure.

Worked example
Two related molecules can behave differently because one circulates attached to albumin while the other is cleared more quickly.
Amino acid: A small organic building block used to make peptides and proteins.

Worked example
Reading a peptide sequence is like reading a short chain of named amino-acid building blocks in order.
Anabolic: Describes processes that build larger molecules or tissues from smaller components.

Worked example
A claim about tissue building is anabolic; a claim about breaking stored material down is catabolic.
Angiogenesis: The formation of new blood vessels from existing vessels.

Worked example
A wound-healing paper may measure endothelial migration as one sign that angiogenesis-related activity occurred.
Antagonist: A molecule that binds to a receptor and blocks or reduces activation by another signal.

Worked example
An antagonist can occupy the receptor without delivering the activating message an agonist would send.

B

↑

Bacteriostatic water (BAC water): Sterile water containing a preservative that inhibits bacterial growth; it is not interchangeable with every other diluent.

Worked example
A protocol should name its intended diluent rather than using the vague instruction “add water.”
Beyond-use date (BUD): The date after which a prepared or compounded product should not be used, based on its preparation and storage conditions.

Worked example
A label can carry a beyond-use date that is different from the manufacturer's expiration date on an unopened product.
Bioavailability: The fraction of an administered substance that reaches systemic circulation in an active form.

Worked example
Two routes can deliver the same molecule yet produce different exposure because their bioavailability differs.
Bioidentical: Chemically identical to a molecule produced naturally by the body.

Worked example
The term describes molecular identity; it does not by itself establish safety, quality, or clinical benefit.
Biomarker: A measurable biological feature used as an indicator of a process, exposure, or response.

Worked example
A study may show a biomarker changed without proving that participants experienced a meaningful clinical benefit.
Blend: A prepared product containing more than one active ingredient in the same container.

Worked example
A blend must be read component by component because one combined concentration cannot describe every active ingredient.

C

↑

Certificate of Analysis (COA): A document reporting tests performed on a specific batch, such as identity, purity, or contamination checks.

Worked example
A useful COA matches the product's batch identifier instead of presenting an unrelated generic report.
Citation: A reference that lets readers locate the source behind a factual claim.

Worked example
A strong evidence section places the citation beside the claim it supports rather than in an unexplained list at the bottom.
Clearance: The body's removal of a substance from circulation through metabolism, excretion, or degradation.

Worked example
A pharmacokinetic summary can distinguish how quickly a compound is cleared from how long downstream signaling persists.
Cold chain: A temperature-controlled handling system maintained during storage and transport.

Worked example
A travel plan is incomplete if it names a cooler but never verifies that the product stayed within its labeled conditions.
Concentration: The amount of a substance contained in a given volume of solution.

Worked example
The vial label states total content, while concentration describes how that content is distributed through the final solution.
Contraindication: A condition or circumstance in which a product or intervention should not be used because risk may outweigh benefit.

Worked example
A contraindication is stronger than a general caution and should not be softened into a vague “be careful” note.
Cycle: A planned period of use followed by a planned stop, break, or reassessment.

Worked example
A complete cycle description names both the active period and the break instead of inventing a missing off-period.
Cytoprotection: Protection of cells from injury caused by stressors such as toxins, inflammation, or loss of blood flow.

Worked example
A cell-protection result in an animal model is preclinical evidence, not automatic proof of a human treatment effect.

D

↑

DAC (Drug Affinity Complex): A chemical modification designed to increase binding to circulating proteins and extend persistence.

Worked example
Two similarly named compounds can have different timing because only one includes a DAC modification.
Dead volume: Fluid that remains inside a syringe or connection space and is not delivered or transferred.

Worked example
A measurement can look exact on the barrel while the equipment's dead volume still affects what actually leaves it.
Degradation: Chemical or structural change that reduces a molecule's integrity, purity, or activity.

Worked example
Cloudiness can trigger a discard decision, but a solution can also degrade without an obvious visual change.
Diluent: A compatible liquid used to dissolve or dilute a product.

Worked example
The correct diluent comes from the product or pharmacy instructions, not from assuming every clear liquid is equivalent.
Discard-by date: A clearly marked date used to show when an opened or prepared item should be discarded.

Worked example
Writing the discard-by date on the label is easier to audit than trying to remember when the container was first opened.
Draw volume: The volume of liquid pulled into a syringe for a measurement or transfer.

Worked example
A calculator can translate a target amount into draw volume only after the concentration and syringe scale are known.

E

↑

Evidence grade: A concise rating of how direct, consistent, and clinically relevant the available evidence is.

Worked example
A page can show strong animal evidence and insufficient human evidence at the same time without averaging them into one vague score.

F

↑

FDA-approved: Authorized by the U.S. Food and Drug Administration for specified conditions, formulations, and labeling.

Worked example
Approval of one branded formulation does not automatically approve every compounded or research version with a similar ingredient name.
Freeze-thaw cycle: One complete sequence of freezing and thawing that can stress a solution or protein structure.

Worked example
Repeatedly moving the same container between frozen and liquid states creates multiple freeze-thaw cycles.

G

↑

GHRH: Growth hormone-releasing hormone, a hypothalamic signal that stimulates the pituitary to release growth hormone.

Worked example
A mechanism chart places GHRH upstream of pituitary growth-hormone release rather than treating it as growth hormone itself.
GHRP: Growth hormone-releasing peptide, a class of secretagogues that can stimulate growth-hormone release through ghrelin-related signaling.

Worked example
The class name describes a signaling role and does not mean every GHRP has identical selectivity or evidence.
GLP-1: Glucagon-like peptide-1, an incretin hormone involved in glucose-dependent insulin signaling, appetite, and gastric emptying.

Worked example
A dual- or triple-agonist page should name each receptor target rather than reducing the mechanism to “a GLP-1.”
Good Manufacturing Practice (GMP): Quality-system requirements governing consistent manufacturing, controls, records, and testing.

Worked example
A GMP claim concerns the manufacturing system; it is not a substitute for reviewing the batch-specific test record.
Growth hormone (GH): A pituitary hormone that regulates growth, metabolism, and signaling to tissues including the liver.

Worked example
A secretagogue prompts the body to release GH; it is not the same molecule as GH itself.

H

↑

Half-life: The time required for the measured amount or concentration of a substance to fall by half under defined conditions.

Worked example
Half-life helps explain persistence, but it does not by itself tell a reader when an effect starts or ends.
HPLC: High-performance liquid chromatography, a technique used to separate and measure components in a sample.

Worked example
An HPLC purity result can show how much material appears in the main peak but may not independently prove molecular identity.

I

↑

IGF-1: Insulin-like growth factor 1, a hormone produced mainly in the liver in response to growth-hormone signaling.

Worked example
A mechanism summary should distinguish a direct GH signal from a downstream IGF-1 response.
IM (intramuscular): A route that places a product into muscle tissue.

Worked example
If evidence used an intramuscular route, a page should not silently present that result as evidence for another route.
International Unit (IU): A potency-based unit defined for a particular biological substance; it is not a universal mass conversion.

Worked example
An IU value for one biologic cannot be converted to mass using a rule borrowed from another product.
Investigational: Still under study and not established as approved for the described use.

Worked example
An investigational badge should remain visible even when preclinical findings are promising.
In vitro: Studied outside a living organism, such as in cells, tissue, or a laboratory system.

Worked example
A result in cultured cells can explain a mechanism without proving the same outcome occurs in a person.
In vivo: Studied within a living organism.

Worked example
An in-vivo animal result is more biologically integrated than a cell result but still may not translate to humans.
IV (intravenous): A route that delivers a product directly into a vein under appropriate clinical or research conditions.

Worked example
A study using intravenous administration cannot automatically establish exposure for an oral or subcutaneous route.

L

↑

Loading dose: An intentionally larger initial amount used in some validated regimens to reach a target exposure sooner.

Worked example
A loading phase should be shown only when the source regimen actually includes one, not inferred from a high first entry.
Lyophilization: Freeze-drying: removal of water under low temperature and vacuum to leave a dry, more stable material.

Worked example
A lyophilized cake and a mixed liquid are different physical states with different handling instructions.

M

↑

Mechanism of action (MOA): The biological process through which a substance produces an effect.

Worked example
“Binds a receptor” is the start of a mechanism; the pathway from binding to the observed outcome completes the explanation.
Meta-analysis: A statistical synthesis that combines results from multiple studies meeting stated criteria.

Worked example
A meta-analysis can increase precision, but it cannot repair weak or incompatible source studies.
mcg (microgram): A metric unit of mass smaller than a milligram.

Worked example
Writing the unit beside every quantity prevents a reader from mistaking micrograms for milligrams.
mg (milligram): A metric unit of mass used to describe ingredient content or measured amounts.

Worked example
A vial's milligram label describes total mass, not the concentration until a final volume is known.
mL (milliliter): A metric unit of liquid volume.

Worked example
Milliliters describe volume, while syringe marks may use a different label that depends on the syringe scale.
Multi-dose vial: A vial designed or prepared to allow more than one withdrawal while following its labeling and handling requirements.

Worked example
Calling a container multi-dose does not make its contents usable indefinitely; the label and beyond-use date still control.

O

↑

Off-label: Use of an approved medical product in a way not included in its approved labeling.

Worked example
Off-label does not mean unregulated or automatically unsafe, but it does require a prescriber's clinical judgment.

P

↑

Peptide: A chain of amino acids shorter than most proteins, with properties determined by sequence and structure.

Worked example
Two peptides with similar names can act differently because a small sequence change alters receptor binding or stability.
Pharmacodynamics (PD): What a substance does to the body, including receptor activity and biological response.

Worked example
Receptor activation is pharmacodynamics; the blood concentration over time is pharmacokinetics.
Pharmacokinetics (PK): What the body does to a substance through absorption, distribution, metabolism, and elimination.

Worked example
A PK graph can show exposure changing over time without claiming that the curve itself proves benefit.
Placebo: An inactive or comparison intervention used to help separate treatment effects from expectation and background change.

Worked example
A placebo-controlled design makes it easier to tell whether an observed difference exceeds normal variation and expectation.
Potency: The amount of a substance needed to produce a defined biological effect; potency is not the same as total effectiveness.

Worked example
A more potent compound may act at a smaller amount without producing a better maximum outcome.
Preclinical: Research conducted before or outside confirmatory human clinical testing, commonly in cells or animals.

Worked example
A repair effect in rodents belongs in the preclinical column even when the mechanism looks relevant to people.

R

↑

Randomized controlled trial (RCT): A study that assigns participants to groups by chance and compares outcomes under controlled conditions.

Worked example
Randomization helps balance known and unknown differences that could otherwise bias the comparison.
Receptor: A cellular protein that recognizes a signal and initiates or changes biological activity.

Worked example
A molecule can bind several receptors, so a complete profile names the relevant targets instead of assuming one pathway.
Reconstitution: Preparing a dry product as a solution using the specific diluent and method required by its labeling or qualified source.

Worked example
Reconstitution changes physical form; it does not change the labeled amount of active material in the sealed vial.
Regulatory status: A product's legal and approval position in a specific jurisdiction and for a specific use.

Worked example
The same molecule may be approved for one indication, investigational for another, and restricted differently across countries.
Route: The path by which a substance is administered or delivered.

Worked example
Evidence from one route should be labeled clearly rather than used as if every route has equivalent exposure.

S

↑

Secretagogue: A substance that stimulates the body to release another substance, often a hormone.

Worked example
A growth-hormone secretagogue encourages endogenous release instead of being growth hormone itself.
Sequence: The exact order of amino acids in a peptide or protein.

Worked example
Checking the sequence helps distinguish a full protein from a shorter fragment with a related name.
Shelf life: The period a product is expected to remain within specification when unopened and stored as labeled.

Worked example
Shelf life for a sealed dry product should not be copied onto a prepared liquid as though the clocks were identical.
Somatropin: Recombinant human growth hormone with the same amino-acid sequence as the principal human form.

Worked example
Somatropin is growth hormone itself, unlike a secretagogue that prompts the pituitary to release hormone.
Stack: Use or study of more than one compound within the same broader protocol; it does not necessarily mean sharing a syringe or vial.

Worked example
Two compounds can appear in the same stack while still requiring separate preparation and compatibility review.
Stability: A product's ability to maintain identity, strength, quality, and purity under defined conditions.

Worked example
A solution can look clear and still require disposal when its validated stability window has ended.
Sterile water: Water prepared to meet sterility requirements but without the preservative found in bacteriostatic water.

Worked example
Sterile water and BAC water may look alike, yet a protocol should not treat them as interchangeable.
SubQ / SC (subcutaneous): A route that places a product into the tissue beneath the skin.

Worked example
A study's subcutaneous route should be kept visible beside its findings so readers do not generalize to other routes.
Synergy: An interaction in which a combination produces an effect greater than expected from the parts alone.

Worked example
Calling a pair synergistic requires evidence of interaction, not merely two positive descriptions placed side by side.
Systematic review: A structured synthesis that searches for, selects, and appraises studies using predefined methods.

Worked example
A systematic review can reveal that many articles exist while the human evidence remains sparse.

T

↑

Titration: A planned adjustment made in steps while monitoring response, tolerability, or a measured target.

Worked example
A titration section should preserve the source sequence and explain the reason for adjustment rather than inventing missing steps.
Tolerance: A reduced response after repeated exposure, sometimes leading to pressure to increase use.

Worked example
A report of diminishing effect may reflect tolerance, progression of the underlying condition, or measurement noise and needs context.
Translational gap: The uncertainty between findings in laboratory or animal research and outcomes in humans.

Worked example
A mechanism can be compelling while the translational gap remains open because no adequate human trial has tested it.

U

↑

U-100 syringe: An insulin syringe scale in which the full milliliter is divided into one hundred equal marked units; the name makes the scale explicit.

Worked example
A calculator labels the barrel U-100 so “units” cannot be mistaken for an international potency unit.
Units: syringe marks vs. IU: Syringe units are volume markings on a specified barrel, while international units describe product-specific biological potency.

Worked example
The word “units” is ambiguous until the page states whether it means a syringe scale or international potency.

V

↑

VEGF: Vascular endothelial growth factor, a signaling protein involved in blood-vessel growth and vascular permeability.

Worked example
A rise in VEGF-related signaling can support an angiogenesis mechanism without proving a complete healing outcome.
Vial: A sealed container used to hold a dry or liquid product.

Worked example
The vial label identifies what is in the container; the protocol page explains how to interpret that label without creating a separate URL for every size.

W

↑

WADA: The World Anti-Doping Agency, which publishes the international Prohibited List used by many sports organizations.

Worked example
An athlete checks the current list and their own governing body's rules because status can depend on substance, route, timing, and competition context.
Washout period: A planned interval intended to allow an intervention's effects or presence to diminish before another phase or measurement.

Worked example
A research protocol can include washout to reduce carryover between study periods.